Sanjeev M. Bijukchhe, Nepal
Patan Academy of Health Sciences Department of PaediatricsAuthor Of 12 Presentations
COMPARISON OF NASOPHARYNGEAL CARRIAGE OF PNEUMOCOCCUS AND ITS SEROTYPES AMONG NEPALI CHILDREN HOSPITALIZED WITH SEVERE AND NON-SEVERE PNEUMONIA (ID 764)
- Animesh Khulal, Nepal
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Sunaina Gurung, Nepal
- Sonu K. Yadav, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Merryn Voysey, United Kingdom
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
IMPACT OF THE INTRODUCTION OF THE PNEUMOCOCCAL CONJUGATE VACCINE ON PAEDIATRIC PNEUMONIA CASES IN NEPAL (ID 543)
- Ganesh Shah, Nepal
- Meeru Gurung, Nepal
- Merryn Voysey, United Kingdom
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Stephen Thorson, Nepal
- Animesh K. Basnet, Nepal
- Sunaina Gurung, Nepal
- Bhishma Pokhrel, Nepal
- Sarah Kelly, United Kingdom
- Maria D. Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
DETECTION OF NASOPHARYNGEAL VIRUSES IN PAEDIATRIC INPATIENT PNEUMONIA CASES BEFORE AND AFTER THE INTRODUCTION OF PCV10 VACCINE IN NEPAL (ID 329)
- Peter J. O'Reilly, United Kingdom
- Merryn Voysey, United Kingdom
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Marie Voice, United Kingdom
- Leo Calvo-Bado, United Kingdom
- Michael J. Carter, United Kingdom
- Michael Levin, United Arab Emirates
- Shrijana Shrestha, Nepal
- Maria D. Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
ASSOCIATION BETWEEN C-REACTIVE PROTEIN LEVEL AND A RADIOLOGICAL END POINT CONSOLIDATION PNEUMONIA AMONG HOSPITALISED CHILDREN WITH SUSPECTED PNEUMONIA IN NEPAL (ID 618)
- Bibek Khadka, Nepal
- Animesh Khulal, Nepal
- Sunaina Gurung, Nepal
- Meeru Gurung, Nepal
- Stephen Thorson, Nepal
- Shrijana Shrestha, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Puja Amatya, Nepal
- Michael J. Carter, United Kingdom
- Matthew Smedley, United Kingdom
- Sarah Kelly, United Kingdom
- Kate M. Park, United Kingdom
- Merryn Voysey, United Kingdom
- David Murdoch, New Zealand
- Ganesh Shah, Nepal
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- Andrew J. Pollard, United Kingdom
Abstract
Background
S. pneumoniae is one of the most common causes of paediatric bacterial pneumonia. In low-income countries such as Nepal, CRP level and blood culture can be useful in diagnosis assessment. We assessed the association between CRP/blood culture, and pneumonia with end-point consolidation.
Methods
We included children less than 5 years of age admitted with suspected pneumonia to Patan Hospital in 2018 and 2019, whose chest xray, CRP level and blood culture were done. CRP levels >40 mg/dl were considered elevated.
Results
There was a significant difference (p<0.001) in CRP levels between EPC-pneumonia and non-EPC pneumonia cases with a median (IQR) CRP of 46.2 (16, 215) in 141 EPC-pneumonia cases and a median (IQR) CRP of 13 (4, 35) in non-EPC pneumonia cases. The sensitivity and specificity of CRP >40mg/dl to detect EPC pneumonia were 50% and 84% respectively. The area under the ROC curve was 0.727 indicating good discrimination between EPC-pneumonia and non-EPC pneumonia. Among the EPC-pneumonia cases, 62% had elevated CRP and 3.5% had S. pneumoniae positive blood cultures.
Conclusions
There was a significant association between CRP and EPC pneumonia. Blood culture had low sensitivity to detect bacterial pneumonia, nevertheless, CRP may be a useful tool in diagnosis of bacterial pneumonia.
IMPACT OF PCV10 IN NEPAL ON NASOPHARYNGEAL CARRIAGE OF PNEUMOCOCCUS IN YOUNG INFANTS PRIOR TO THEIR VACCINATION (ID 530)
- Subhash Shrestha, Nepal
- Meeru Gurung, Nepal
- Brian Wahl, United States of America
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Pratistha Maskey, Nepal
- Himang M. Maskey, Nepal
- Madhav C. Gautam, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Merryn Voysey, United Kingdom
- Maria D. Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
IS THERE A RELATIONSHIP BETWEEN PREVIOUS HISTORY OF PNEUMONIA, MENINGITIS OR SEPSIS AND NASOPHARYNGRAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN HEALTHY CHILDREN IN NEPAL (ID 752)
- Himang M. Maskey, Nepal
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Pratistha Maskey, Nepal
- Subhash Shrestha, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Merryn Voysey, United Kingdom
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
IMPACT OF NUMBER OF CHILDREN IN THE HOUSEHOLD ON NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN HEALTHY NEPALESE CHILDREN (ID 534)
- Himang M. Maskey, Nepal
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Pratistha Maskey, Nepal
- Subhash Shrestha, Nepal
- Madhav C. Gautam, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Merryn Voysey, United Kingdom
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
DOES VIRAL DETECTION IN THE NASOPHARYNX IMPACT THE DISTRIBUTION OF COLONISING PNEUMOCOCCAL SEROTYPES OBSERVED IN PNEUMONIA CASES AMONG NEPALESE CHILDREN? (ID 799)
- Peter J. O'Reilly, United Kingdom
- Merryn Voysey, United Kingdom
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Stephen Thorson, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Marie Voice, United Kingdom
- Leo Calvo-Bado, United Kingdom
- Michael J. Carter, United Kingdom
- Michael Levin, United Arab Emirates
- Shrijana Shrestha, Nepal
- Maria D. Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
IMPACT OF 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION ON INVASIVE PNEUMOCOCCAL DISEASE (IPD) IN NEPALESE CHILDREN (ID 563)
- Meeru Gurung, Nepal
- Merryn Voysey, United Kingdom
- Stephen Thorson, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Michael J. Carter, United Kingdom
- Bibek Khadka, Nepal
- Animesh Khulal, Nepal
- Sunaina Gurung, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
Abstract
Background
We assessed the distribution of pneumococcal serotypes in children with microbiologically-confirmed invasive pneumococcal disease (IPD) before (2014-2015) and after (2016-2019) PCV10 introduction in Nepal in 2015.
Methods
Children (aged 2 months to <14 years) admitted to Patan Hospital, Nepal with pneumococcus detected in blood, CSF or pleural fluid were included. Serotyping was by Quellung method.
Results
Pre-vaccine, 6/22 (27.3%) IPD cases were age <2 years; post-vaccine, 5/36 (13.9%) were <2 years. Ratio of vaccine-type to non-vaccine-type IPD among <2y olds was 5:1 pre-vaccine and 2:3 post-vaccine; among >=2y olds, the ratio was 13:1 pre-vaccine and 7:1 post-vaccine. Most (32/41, 78%) vaccine-type IPD was serotype 1: 3/7 among <2 year olds (n=1 post-vaccine); 29/34 among >=2 year olds (n=17/19 post-vaccine were >4 years old). Among 44 IPD cases detected from blood, 36 (82%) were vaccine-type (n=29 were ST1), and 7 were non-vaccine-type (6C, 10A (n=2), 19A, 24F, 38, 41). Of 13 detected from CSF (1 culture, 3 PCR and 9 Binax-only), 5 were serotyped (1, 14, 6B, 6A/B, 7F) .The 3 pleural fluid cases were serotypes 1 (n=2) and 19A.
Conclusions
Post-PCV10 introduction, IPD among <2 year olds fell; although a high proportion of ST1 IPD remains, most were >4 years old.
NASOPHARYNGEAL CARRIAGE PREVALENCE OF SEROTYPES 3, 6A, 19A AND 6C IN NEPALESE CHILDREN: IS IT TIME TO SWITCH FROM PCV10 TO A DIFFERENT PCV? (ID 528)
- Pratistha Maskey, Nepal
- Meeru Gurung, Nepal
- Sanjeev M. Bijukchhe, Nepal
- Peter J. O'Reilly, United Kingdom
- Himang M. Maskey, Nepal
- Subhash Shrestha, Nepal
- Stephen Thorson, Nepal
- Madhav C. Gautam, Nepal
- Bhishma Pokhrel, Nepal
- Ganesh Shah, Nepal
- Imran Ansari, Nepal
- Sarah Kelly, United Kingdom
- Merryn Voysey, United Kingdom
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- David Murdoch, New Zealand
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
ANTIMICROBIAL SUSCEPTIBILITY PROFILE AND SEROTYPE DISTRIBUTION OF PNEUMOCOCCAL BLOOD CULTURE ISOLATES FROM NEPALESE CHILDREN (ID 672)
- Krishna G. Prajapati, Nepal
- Madhav C. Gautam, Nepal
- Bhishma Pokhrel, Nepal
- Peter J. O'Reilly, United Kingdom
- Meeru Gurung, Nepal
- Merryn Voysey, United Kingdom
- Sanjeev M. Bijukchhe, Nepal
- Sarah Kelly, United Kingdom
- Ganesh Shah, Nepal
- Stephen Thorson, Nepal
- David Murdoch, New Zealand
- Dominic Kelly, United Kingdom
- Maria D. Knoll, United States of America
- Andrew J. Pollard, United Kingdom
- Shrijana Shrestha, Nepal
IMPACT OF PCV10 INTRODUCTION ON NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN HEALTHY CHILDREN IN RURAL AND URBAN NEPAL (ID 531)
- Madhav Chandra Gautam, Nepal
- Sonu Shrestha, United Kingdom
- Sanjeev M. Bijukchhe, Nepal
- Meeru Gurung, Nepal
- Bhishma Pokhrel, Nepal
- Merryn Voysey, United Kingdom
- Peter J. O'Reilly, United Kingdom
- Sarah Kelly, United Kingdom
- Ganesh Shah, Nepal
- Laxmi Lama, Nepal
- Pratistha Maskey, Nepal
- Stephen Thorson, Nepal
- David Murdoch, New Zealand
- Maria Deloria Knoll, United States of America
- Dominic Kelly, United Kingdom
- Shrijana Shrestha, Nepal
- Andrew J. Pollard, United Kingdom
Abstract
Background
The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in Nepal in 2015. We compared the nasopharyngeal carriage of PCV10 and non-PCV10 serotypes of pneumococcus between pre-vaccine (2015) and post-vaccine (2017-2018) years in two different regions of Nepal.
Methods
Nasopharyngeal samples obtained in healthy Nepalese children aged 6-59 months in urban (Patan, Kathmandu) and 6-23 months in rural (Okhaldhunga) settings were transported in STGG (Skim Milk-Tryptone-Glucose-Glycerol) media, cultured for pneumococcus and serotyped by the Quellung method.
Results
The carriage prevalence decreased for all PCV10-type serotypes except 7F in both the settings. PCV10-type prevalence decreased from 29.7% in rural and 17.2% in urban children pre-vaccine to 9.0% and 8.6% post-vaccine, respectively. Pre-vaccine, the most frequently found serotypes in both settings were 19F, 6B, 14. Post-vaccine, the non-PCV10 serotypes were more common; serotypes 34, 6C, 19A and 15B were most common in rural and 6A, 34, 11A, 6C and 15B in urban settings.
Conclusions
Since the introduction of PCV10, carriage prevalence of PCV10 serotypes have reduced and non-PCV10 serotypes have increased in both settings raising the possibility of replacement disease. Continued monitoring of changes in PCV10-serotypes and non-PCV10 serotypes, especially those covered by PCV13, is important to assess vaccine impact.